Top 10 Value Stocks to Buy Under $10

7. Grifols (NASDAQ:GRFS)

Number of Hedge Fund Holders: 16

Grifols (NASDAQ:GRFS) is one of the top value stocks to buy under $10. On June 15, Grifols launched FESILTY in the US for treating acute bleeding in pediatric and adult patients with congenital fibrinogen deficiency/CFD, excluding dysfibrinogenemia. This highly purified human-derived fibrinogen concentrate provides a precise, targeted treatment for a rare genetic condition where insufficient clotting proteins compromise wound healing.

Compared to traditional options like cryoprecipitate or fresh frozen plasma, FESILTY allows for faster, more predictable dosing without needing large-volume infusions or cross-matching. It comes in a complete kit that can be stored at room temperature and reconstituted in approximately three minutes, making it effective for time-sensitive bleeding events.

FDA approval for this therapy was supported by Phase I/III clinical study data, which confirmed its safety, pharmacokinetic properties, and hemostatic efficacy. While effective, the product carries risks, including potential hypersensitivity and thrombotic events, and is contraindicated in patients with severe hypersensitivity to its components.

Grifols (NASDAQ:GRFS) is a global healthcare company specializing in plasma-derived medicines. Founded in Barcelona in 1909, it provides biopharmaceutical products and medical services in over 110 countries.